CD79A and COVID-19: During the COVID-19 outbreak, Seitz-Polski group found that the proportion of patients with positive SARS-CoV-2-specific IgA and IgG at admission was 9/13 (69%) and 6/13 (46%), respectively, and reached 100% for the two isotypes after 15 days of hospitalization.